Studies of noradrenergic influence on cardiac ornithine decarboxylase in rats.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002262:Carboxy-Lyases / Q000378:metabolism*; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D009638:Norepinephrine / Q000494:pharmacology; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D005082:Physical Exertion; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats
D000319:Adrenergic beta-Antagonists; D006892:Hydroxydopamines; D010647:Phenyl Ethers; D011437:Propylamines; D010643:Phenoxybenzamine; D011433:Propranolol; D002262:Carboxy-Lyases; D009955:Ornithine Decarboxylase; D009638:Norepinephrine